Trial Profile
A phase I study of celecoxib, irinotecan and concurrent radiotherapy in the preoperative treatment of pancreatic cancer
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2010
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Irinotecan (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 01 Jul 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 29 Oct 2005 New trial record.